Clinical Trial Update: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating allogeneic mesenchymal stem cells for degenerative disc disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Intervertebral Disc Disease
• Low Back Pain

Drugs mentioned

• Allogenic Mesenchymal Stem Cells (MSV) (allogeneic mesenchymal stem cells)

Snippet

Sponsor: Red de Terapia Celular | Conditions: Degenerative Disc Disease, Intervertebral Disc Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-04-29